Get the Stockscreener App
14.14
0.04%
0.005
Lensar Inc stock is traded at $14.14, with a volume of 56,196.
It is up +0.04% in the last 24 hours and up +8.81% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
See More
Previous Close:
$14.14
Open:
$14.15
24h Volume:
56,196
Relative Volume:
0.42
Market Cap:
$166.70M
Revenue:
$42.16M
Net Income/Loss:
$-14.38M
P/E Ratio:
-7.9022
EPS:
-1.79
Net Cash Flow:
$-9.90M
1W Performance:
-4.55%
1M Performance:
+8.81%
6M Performance:
+218.58%
1Y Performance:
+316.40%
1-Day Range:
$14.14
$14.20
1-Week Range:
$14.06
$14.58
52-Week Range:
$2.67
$17.31
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
14.14 | 166.70M | 42.16M | -14.38M | -9.90M | -1.79 |
|
ABT
Abbott Laboratories
|
131.84 | 229.15B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
99.12 | 145.39B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
364.50 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.45 | 112.64B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.89 | 41.85B | 5.72B | 4.17B | 259.90M | 6.97 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
Alcon Inc’s Acquisition of LENSAR Inc - Global Legal Chronicle
Related Content: Alcon to Acquire LENSAR | Business | Mar 2025 - Photonics.com
Alcon to buy Lensar in deal worth up to $430M - The Business Journals
Alcon to Acquire LENSAR | Business | Mar 2025 - Photonics.com
ALC Stock Rises Following the Merger Agreement With LENSAR - MSN
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc.LNSR - Business Wire
Alcon lines up Lensar deal to expand laser cataract surgery options - Optics.org
Alcon signs merger agreement to acquire Lensar - Yahoo
BTIG Research Downgrades LENSAR to Neutral From Buy - Marketscreener.com
Alcon agrees to purchase LENSAR - Ophthalmology Times
Switzerland: Alcon agrees acquisition of Lensar for up to US$430m - Investors in Healthcare
LENSAR’s (LNSR) “Hold” Rating Reaffirmed at Lake Street Capital - Defense World
Alcon Agrees to Acquire Lensar, Inc. for Up to $430 Million - Vision Monday
BTIG cuts LENSAR stock rating post Alcon acquisition deal - Investing.com India
BTIG cuts LENSAR stock rating post Alcon acquisition deal By Investing.com - Investing.com Australia
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of LENSAR, Inc.LNSR - The Malaysian Reserve
Latham & Watkins Represents LENSAR, Inc. in Acquisition by Alcon - Latham & Watkins LLP
Alcon to Acquire LENSAR in $430M Deal - USA Herald
Alcon to acquire Lensar for up to $430M - BioWorld Online
Norton Rose, Latham Steer Alcon's $430M Lensar Buy - Law360
Alcon agrees to acquire LENSAR for $14.00 per share - MSN
Alcon to acquire LENSAR for up to $430 million By Investing.com - Investing.com South Africa
Alcon to Acquire Lensar for up to $430 million. - MD+DI
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of LENSAR, Inc. (LNSR) - TradingView
Alcon Agrees to Acquire LENSAR, Inc. - Sharewise
Lake Street Downgrades LENSAR to Hold From Buy, Price Target is $15 -March 24, 2025 at 11:54 am EDT - Marketscreener.com
Alcon Eyes Surgical Edge With LENSAR Buyout: Details - Benzinga
Switzerland's Alcon to Buy US-based Medical Technology Group Lensar -March 24, 2025 at 09:48 am EDT - Marketscreener.com
Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public Shareholders - Business Wire
LNSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LENSAR, Inc. Is Fair to Shareholders - Bluefield Daily Telegraph
Alcon to Buy Lensar for up to $430 Million - MPO-mag
Alcon to Acquire Lensar for $430 Million -March 24, 2025 at 08:42 am EDT - Marketscreener.com
Alcon to acquire LENSAR for up to $430 million - Investing.com
LENSAR Announces Merger Agreement with Alcon - TipRanks
Alcon Agrees To Acquire LENSAR For Up To Approximately $430 Mln - Nasdaq
Alcon Agrees To Acquire Lensar, Inc. -March 24, 2025 at 08:03 am EDT - Marketscreener.com
Major Medical Tech Deal: Alcon Buys LENSAR at 47% Premium, Eyes $32B Cataract Market - StockTitan
LENSAR, Inc. (NASDAQ:LNSR) Shares Purchased by Atria Investments Inc - Defense World
LENSAR Announces Application for Certification of the ALLY Adaptive Cataract Treatment System in the EU - Business Wire
LENSARTop Healthcare Equipment Stock - Inkl
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
LENSAR announces inducement grants - Medical Buyer
Lensar Inc. Reports Record Revenue and Optimistic Outlook - TipRanks
LENSAR Awards New Hires Stock Options at $13.48What This Means for Shareholders - StockTitan
LENSAR, Inc. (NASDAQ:LNSR) Q4 2024 Earnings Call Transcript - Insider Monkey
LENSAR (NASDAQ:LNSR) Price Target Raised to $16.00 - Defense World
LENSAR revenue jumps 38% to USD 16.7M in Q4 2024 - Medical Buyer
LENSAR (NASDAQ:LNSR) Announces Quarterly Earnings Results - MarketBeat
LENSAR Inc (LNSR) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... - Yahoo Finance
LENSAR, Inc. Reports Strong 2024 Financial Performance - TipRanks
LENSAR, Inc. SEC 10-K Report - TradingView
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lensar Inc Stock (LNSR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Winer Gary M | Director |
Aug 28 '24 |
Buy |
4.45 |
1,000 |
4,450 |
80,155 |
| Winer Gary M | Director |
Aug 26 '24 |
Buy |
4.58 |
802 |
3,673 |
78,655 |
| Winer Gary M | Director |
Aug 27 '24 |
Buy |
4.50 |
500 |
2,250 |
79,155 |
| Winer Gary M | Director |
Aug 21 '24 |
Buy |
4.35 |
500 |
2,176 |
77,851 |
| Winer Gary M | Director |
Aug 22 '24 |
Buy |
4.30 |
2 |
9 |
77,853 |
| Winer Gary M | Director |
Aug 20 '24 |
Buy |
4.20 |
500 |
2,100 |
77,351 |
| Winer Gary M | Director |
Aug 16 '24 |
Buy |
4.03 |
6 |
24 |
76,851 |
| Winer Gary M | Director |
Aug 14 '24 |
Buy |
4.20 |
1,000 |
4,200 |
76,845 |
| Winer Gary M | Director |
Aug 12 '24 |
Buy |
4.03 |
500 |
2,015 |
75,845 |
| STAAB THOMAS R II | Chief Financial Officer |
Aug 08 '24 |
Option Exercise |
2.65 |
3,500 |
9,275 |
162,434 |
0.35%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):